Literature DB >> 7909496

Effects of CD4+ and CD8+ T cells in tumor-bearing mice on antibody production.

M Shimizu1, T Iwaguchi.   

Abstract

The function of T cell subsets in tumor-bearing mice was examined using an in vitro culture system of anti-(sheep red blood cell) antibody production, which is known to be dependent on T cells. The helper function of T cells of fibrosarcoma-MethA-bearing mice in antibody production decreased with the tumor stage of the mice. T cells were separated into CD4+ and CD8+ cells for further analysis of T cell subsets by the panning method using monoclonal antibodies. The helper function of CD4+ T cells in antibody production began to decrease significantly in tumor-bearing mice 1 week after the tumor transplantation. On the other hand, the suppressive function of CD8+ T cells was retained and had not decreased in the mice even 3 weeks after the transplantation. The same changes in function of CD4+ and CD8+ T cells were also observed in Meth1-bearing mice. These results suggested that this tumor-associated immunosuppression in antibody production is attributable to the decrease in helper activity of CD4+ T cells and the maintenance of the suppressive activity of CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7909496

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  27 in total

1.  Plaque formation in agar by single antibody-producing cells.

Authors:  N K JERNE; A A NORDIN
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

2.  Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.

Authors:  T Tada; S Ohzeki; K Utsumi; H Takiuchi; M Muramatsu; X F Li; J Shimizu; H Fujiwara; T Hamaoka
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

Review 3.  Suppressor cells: permitters and promoters of malignancy?

Authors:  D Naor
Journal:  Adv Cancer Res       Date:  1979       Impact factor: 6.242

Review 4.  Cell-mediated immunity to tumor cells.

Authors:  R B Herberman
Journal:  Adv Cancer Res       Date:  1974       Impact factor: 6.242

5.  Mouse macroglobulin antibody to sheep erythrocytes: a non-complement-fixing type.

Authors:  P H Plotz; H Colten; N Talal
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

Review 6.  A functional dichotomy in CD4+ T lymphocytes.

Authors:  K Bottomly
Journal:  Immunol Today       Date:  1988-09

7.  Tumor dependency of concanavalin A-induced potentiation of tumor cell immunogenicity.

Authors:  T Kataoka; F Oh-hashi; Y Akabori; Y Sakurai; M Okabe; K Gomi
Journal:  Gan       Date:  1983-06

8.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.

Authors:  R K Assoian; A Komoriya; C A Meyers; D M Miller; M B Sporn
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

9.  Identification and characterization of a tumor-derived immunosuppressive glycoprotein from murine melanoma K-1735.

Authors:  J B Putnam; J A Roth
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

10.  Suppression of the generation of lymphokine-activated killer (LAK) cells by serum-free supernatants of in vitro maintained tumour cell lines.

Authors:  P J Guillou; C W Ramsden; S S Somers; P C Sedman
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.